Genix Pharmaceuticals (GENX) Financial Statements

1 Followers

Genix Pharmaceuticals Financial Overview

Genix Pharmaceuticals's market cap is currently C$918.36K. The company's EPS TTM is C$-0.001; its P/E ratio is -3.00; Genix Pharmaceuticals is scheduled to report earnings on June 27, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Oct 23	Oct 22	Oct 21	Oct 20	Oct 19
Income Statement
Total Revenue
Gross Profit	$ 3.26K	-	-	-	$ -45.69K
Operating Income	$ -880.89K	$ -1.03M	$ -1.65M	$ -715.21K	$ -143.34K
EBITDA	$ -3.80M	$ -497.69K	$ -1.11M	$ -353.21K	$ -162.67K
Net Income	$ -4.40M	$ -1.07M	$ -1.65M	$ -718.66K	$ -164.70K
Balance Sheet
Cash & Short-Term Investments	$ ―	$ ―	$ ―	$ ―	$ ―
Total Assets	$ 223.46K	$ 4.25M	$ 4.77M	$ 5.35M	$ 40.27K
Total Debt	$ 511.52K	$ 182.50K	$ 48.94K	$ 155.18K	$ 20.58K
Net Debt	$ 499.89K	$ 173.24K	$ -89.87K	$ -541.42K	$ -10.76K
Total Liabilities	$ 1.36M	$ 1.05M	$ 755.19K	$ 489.88K	$ 82.41K
Stockholders' Equity	$ ―	$ ―	$ ―	$ ―	$ ―
Cash Flow
Free Cash Flow	$ -220.67K	$ -222.92K	$ -428.31K	$ -195.03K	$ -58.55K
Operating Cash Flow	$ -220.67K	$ -219.58K	$ -428.31K	$ -195.03K	$ -58.55K
Investing Cash Flow
Financing Cash Flow

Genix Pharmaceuticals Earnings and Revenue History

Income Statement >

Genix Pharmaceuticals Debt to Assets

Balance Sheet >

Genix Pharmaceuticals Cash Flow

Cash Flow >

Genix Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >